Jordyn Sava is an editor for Targeted Oncology.
Osimertinib Combo Significantly Reduces CNS Progression in EGFRm NSCLC
February 9th 2024The FLAURA2 study found that osimertinib with platinum-pemetrexed was more effective than osimertinib monotherapy in preventing central nervous system progression or death in patients with EGFR-mutated advanced non–small cell lung cancer.
Real-World Data Confirms Efficacy of Tafasitamab for R/R DLBCL
February 8th 2024In an interview with Targeted Oncology, Bruce Feinberg, DO, discussed the importance of real-world data, highlighting recent findings on tafasitamab for the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma in the United States.
Dehumanizing Language is a Top Culprit in Prostate Cancer Research
February 7th 2024In an interview with Targeted Oncology, Regina Barragan-Carrillo, MD, discussed the findings from her analysis of the Language of Respect guidelines adopted by the American Society of Clinical Oncology and how well they are followed in prostate cancer abstracts.
In R/R Myeloma, Belantamab Mafodotin/BorDex Outperforms Standard Treatment
February 6th 2024According to an interim analysis of the DREAMM-7 trial, belantamab mafodotin, bortezomib, and dexamethasone achieved a statistically significant and clinically meaningful improvement in progression-free survival among patients with multiple myeloma.
FDA Fast Tracks UV1, Ipilimumab, and Nivolumab in Malignant Mesothelioma
February 5th 2024A fast track designation to UV1 combination therapy for malignant mesothelioma from the FDA signifies expedited review and development for a promising treatment option, offering hope for patients with malignant pleural mesothelioma.
Robotic Surgery Can Effectively Treat High-Risk EC After Prior Hysterectomy
January 30th 2024Robotic peritoneal mesometrial resection with targeted or systemic lymphadenectomy demonstrated feasibility with acceptable complication rates in intermediate/high-risk endometrial cancer requiring second surgery after prior hysterectomy.